Stoke Therapeutics, Inc.STOKNASDAQ
Loading
PB Ratio: Premium ValuationElevated
Percentile Rank75
3Y CAGR+40.0%
5Y CAGR-6.0%
Year-over-Year Change
Price-to-book ratio
3Y CAGR
+40.0%/yr
vs -23.7%/yr prior
5Y CAGR
-6.0%/yr
Recent acceleration
Acceleration
+63.7pp
Accelerating
Percentile
P75
Within normal range
vs 5Y Ago
0.7x
Contraction
Streak
2 yr
Consecutive growthElevated
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 5.33 | +105.0% |
| 2024 | 2.60 | +79.4% |
| 2023 | 1.45 | -25.3% |
| 2022 | 1.94 | -52.0% |
| 2021 | 4.05 | -44.2% |
| 2020 | 7.25 | +219.7% |
| 2019 | 2.27 | -60.4% |
| 2018 | 5.72 | +101.2% |
| 2017 | -465.32 | - |